Faes Farma, S.A. Stock price

Equities

FAE

ES0134950F36

Pharmaceuticals

Market Closed - BME 12:35:12 2024-03-28 pm EDT 5-day change 1st Jan Change
3.145 EUR -0.32% Intraday chart for Faes Farma, S.A. +6.07% -0.47%
Sales 2024 * 476M 514M Sales 2025 * 496M 536M Capitalization 979M 1.06B
Net income 2024 * 89M 96.02M Net income 2025 * 91M 98.18M EV / Sales 2024 * 2.08 x
Net Debt 2024 * 9.8M 10.57M Net cash position 2025 * 64.45M 69.54M EV / Sales 2025 * 1.84 x
P/E ratio 2024 *
10.8 x
P/E ratio 2025 *
10.6 x
Employees 1,748
Yield 2024 *
4.93%
Yield 2025 *
5.01%
Free-Float 90.45%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.32%
1 week+6.07%
Current month+4.83%
1 month+2.11%
3 months-1.41%
6 months-0.47%
Current year-0.47%
More quotes
1 week
3.06
Extreme 3.06
3.20
1 month
2.91
Extreme 2.91
3.20
Current year
2.91
Extreme 2.91
3.27
1 year
2.87
Extreme 2.865
3.44
3 years
2.87
Extreme 2.865
4.29
5 years
2.87
Extreme 2.865
5.48
10 years
1.61
Extreme 1.6127
5.48
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Chief Executive Officer - -
Director of Finance/CFO - -
Members of the board TitleAgeSince
Director/Board Member 65 19-06-18
Chairman - 91-05-15
Director/Board Member - 94-06-25
More insiders
Date Price Change Volume
24-03-28 3.145 -0.32% 99,594
24-03-27 3.155 -0.32% 121,457
24-03-26 3.165 -0.63% 209,273
24-03-25 3.185 +0.95% 216,997
24-03-22 3.155 +3.10% 440,219

Delayed Quote BME, March 28, 2024 at 12:35 pm EDT

More quotes
Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company's research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
3.145 EUR
Average target price
3.708 EUR
Spread / Average Target
+17.89%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Faes Farma, S.A. - BME